Influence of Amifostine on the Toxicity and Pharmacokinetics of Docetaxel in Metastatic Breast Cancer Patients

Preclinical studies suggest that amifostine could protect against toxicities induced by taxoids. We conducted a clinical and pharmacokinetic pilot study to assess the feasibility and toxicity of the docetaxel plus amifostine combination and the absence of influence of amifostine on docetaxel pharmac...

Full description

Saved in:
Bibliographic Details
Published inClinical cancer research Vol. 8; no. 1; p. 95
Main Authors Gilles Freyer, Philippe Hennebert, Ahmad Awada, Thierry Gil, Joseph Kerger, Jean Selleslags, Christiane Brassinne, Martine Piccart, Dominique de Valeriola
Format Journal Article
LanguageEnglish
Published American Association for Cancer Research 01.01.2002
Online AccessGet full text

Cover

Loading…